CIBMTR Reporting Implementation Guide
0.1.8 - Trial Use 1
CIBMTR Reporting Implementation Guide
0.1.8 - Trial Use 1
This page is part of the CIBMTR Reporting Implementation Guide (v0.1.8: Release Draft) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
| Official URL: http://fhir.nmdp.org/ig/cibmtr-reporting/ValueSet/med-cyclophosphamide-vs | Version: 0.1.8 | |||
| Draft as of 2025-02-18 | Computable Name: RxNormCyclophosphamideVS | |||
RxNorm codes for Cyclophosphamide
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Generated Narrative: ValueSet med-cyclophosphamide-vs
http://www.nlm.nih.gov/research/umls/rxnorm| Code | Display |
| 3002 | cyclophosphamide |
| 202589 | Cytoxan |
| 202588 | Endoxana |
| 1545988 | cyclophosphamide anhydrous |
| 221085 | cyclophosphamide lyophilized |
| 1156180 | cyclophosphamide / mannitol Injectable Product |
| 377238 | cyclophosphamide / mannitol Injectable Solution |
| 358855 | cyclophosphamide 10 MG |
| 563185 | cyclophosphamide 10 MG [Endoxana] |
| 102948 | cyclophosphamide 10 MG Oral Tablet [Endoxana] |
| 438828 | cyclophosphamide 10 MG/ML |
| 1734918 | cyclophosphamide 1000 MG |
| 329664 | cyclophosphamide 20 MG/ML |
| 2386858 | cyclophosphamide 200 MG/ML |
| 1734920 | cyclophosphamide 2000 MG |
| 315746 | cyclophosphamide 25 MG |
| 571074 | cyclophosphamide 25 MG [Cytoxan] |
| 210570 | cyclophosphamide 25 MG Oral Tablet [Cytoxan] |
| 438830 | cyclophosphamide 5 MG/ML |
| 315747 | cyclophosphamide 50 MG |
| 571139 | cyclophosphamide 50 MG [Cytoxan] |
| 564082 | cyclophosphamide 50 MG [Endoxana] |
| 210639 | cyclophosphamide 50 MG Oral Tablet [Cytoxan] |
| 105555 | cyclophosphamide 50 MG Oral Tablet [Endoxana] |
| 1734915 | cyclophosphamide 500 MG |
| 438831 | cyclophosphamide 7.5 MG/ML |
| 1156181 | cyclophosphamide Injectable Product |
| 376666 | cyclophosphamide Injectable Solution |
| 1734916 | cyclophosphamide Injection |
| 1437967 | cyclophosphamide Oral Capsule |
| 1156182 | cyclophosphamide Oral Product |
| 371664 | cyclophosphamide Oral Tablet |
| 367922 | cyclophosphamide Oral Tablet [Cytoxan] |
| 368546 | cyclophosphamide Oral Tablet [Endoxana] |
| 1156183 | cyclophosphamide Pill |
| 1174493 | Cytoxan Oral Product |
| 1174494 | Cytoxan Pill |
| 1176602 | Endoxana Oral Product |
| 1176603 | Endoxana Pill |
| 690313 | cyclophosphamide / mannitol |
Generated Narrative: ValueSet
Expansion from tx.fhir.org based on codesystem RxNorm version09032024
This value set contains 40 concepts
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |